Ibrahim Rajiha A, Teshal Amete M, Dinku Surafel F, Abera Negga A, Negeri Abebe A, Desta Feven G, Seyum Eyasu T, Gemeda Adugna W, Keficho Wubshet M
Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
American Society for Microbiology, Addis Ababa, Ethiopia.
Afr J Lab Med. 2018 Dec 6;7(2):770. doi: 10.4102/ajlm.v7i2.770. eCollection 2018.
Antimicrobial resistance (AMR) poses a global threat. High levels of AMR to commonly used antibiotics have been reported in East Africa. A situation analysis of AMR in Ethiopia also indicated high resistance levels. To prevent and contain AMR, Ethiopia established a national surveillance network.
This article describes the steps taken to prioritise AMR and establish the National Antimicrobial Resistance Surveillance System in Ethiopia, as well as present the challenges and lessons learned through implementation.
In April 2017, Ethiopia had developed and approved the National AMR Surveillance Plan for laboratory-based AMR surveillance. The World Health Organization recommendations and Ethiopias's current microbiology capacity were used to prioritise organisms for reporting. The surveillance system is comprised of a network linking the national reference laboratory with surveillance sentinel sites. Roll-out of the AMR surveillance network occurred in three phases in order to ensure successful implementation.
Electronic capture and transmission of data, supply chain for the microbiology laboratory and communication problems were challenges observed after implementation started. Support from Ethiopian Public Health Institute focal persons for data entry, regular scheduled communication establishment and procurement of supplies by the American Society for Microbiology were some of the measures taken to address the challenges.
Ethiopia has demonstrated that setting up AMR surveillance in lower resource settings is possible with strong leadership and stakeholder engagement.
抗菌药物耐药性(AMR)构成全球威胁。据报道,东非对常用抗生素的耐药水平很高。埃塞俄比亚对抗菌药物耐药性的情况分析也表明耐药水平很高。为预防和控制抗菌药物耐药性,埃塞俄比亚建立了一个国家监测网络。
本文描述了埃塞俄比亚为确定抗菌药物耐药性优先事项和建立国家抗菌药物耐药性监测系统所采取的步骤,并介绍了实施过程中遇到的挑战和吸取的经验教训。
2017年4月,埃塞俄比亚制定并批准了基于实验室的抗菌药物耐药性监测国家计划。利用世界卫生组织的建议和埃塞俄比亚目前的微生物学能力来确定报告的病原体优先顺序。监测系统由一个将国家参考实验室与监测哨点连接起来的网络组成。抗菌药物耐药性监测网络分三个阶段推出,以确保成功实施。
实施开始后,观察到数据的电子采集和传输、微生物实验室的供应链以及通信问题等挑战。埃塞俄比亚公共卫生研究所联络人提供数据录入支持、定期建立通信以及美国微生物学会采购物资等是为应对这些挑战采取的一些措施。
埃塞俄比亚表明,在资源较少的环境中建立抗菌药物耐药性监测系统,在强有力的领导和利益相关者参与下是可行的。